K
K. Zhou
Researcher at Amgen
Publications - 1
Citations - 93
K. Zhou is an academic researcher from Amgen. The author has contributed to research in topics: Hazard ratio & Denosumab. The author has an hindex of 1, co-authored 1 publications receiving 85 citations.
Papers
More filters
Journal ArticleDOI
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
Allan Lipton,Karim Fizazi,Alison Stopeck,David H. Henry,Matthew R. Smith,N. Shore,Miguel Martin,Saroj Vadhan-Raj,Janet E. Brown,Gary Richardson,Fred Saad,Denise A. Yardley,K. Zhou,Arun Balakumaran,Ada Braun +14 more
TL;DR: Denosumab was superior to ZA in preventing SREs in patients with bone metastases from advanced cancer, regardless of ECOG PS, bone metastasis number, baseline visceral metastasis presence/absence, and uNTx level.